MolecularMD’s NGS Oncology Panel Service provides validated and optimized NGS panels that include cancer oncogenes and tumor suppressors. This service features PGM AmpliSeq, and MiSeq TruSeq cancer panels, both powered by our proprietary NGS workflow from sample preparation to data reporting. Our NGS Oncology Panel Service is optimized to detect and to report most critical mutations across the targeted genes, beyond the typical reporting of hot spot mutations.

This email address is being protected from spambots. You need JavaScript enabled to view it.

MolecularMD’s NGS oncology custom panel development and service provides customer defined NGS panels that are developed for specific target or multiplexed targeted re-sequencing for specific diseases. Our services provide a streamlined workflow, from sample preparation to customized data reporting.

• CUSTOM SOLUTION

Utilizing the Droplet Digital™ PCR (ddPCR) assay system, MolecularMD has developed a highly sensitive assay for the EGFR T790M mutation in circulating nucleic acids isolated from blood. This 3rd generation PCR technology allows for absolute quantification of EGFR T790M by focusing single fragment amplification in individual droplets offering superior performance in precision and accuracy.

• CUSTOM SOLUTION